Polymorphisms of interleukin-10 and tumour necrosis factor-α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis

Respirology

Volumn 12, Issue 4, 2007, Pages 594-598

  Oh, Jae Hee ^a   Yang, Chul Su ^a   Noh, Yeon Kyeong ^a   Kweon, Yu Mi ^a   Jung, Sung Soo ^a   Son, Ji Woong ^b   Kong, Suck Jun ^c   Yoon, Jang Uk ^c   Lee, Ji Sook ^a   Kim, Hwa Jung ^a   Park, Jeong Kyu ^a   Jo, Eun Kyeong ^a   Song, Chang Hwa ^a  

^a Chungnam National University   (South Korea)

^b Konyang University   (South Korea)

^c National Mokpo Tuberculosis Hospital   (South Korea)

Author keywords

Interleukin 10; Newly diagnosed tuberculosis; Recurrent tuberculosis; Tuberculosis; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECURRENCE; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250729061     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01108.x     Document Type: Article

References (31)

1. World Health Organisation. World Health Organisation Tuberculosis Fact Sheet. [Accessed March 2007.] Available from URL: http://www.who.int
2. Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am. Rev. Respir. Dis. 1967 95 : 729 45.
3. MacNicholl JM, Downer MV, Udhayakumar V, Alper CA, Swerdlow DL. Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera. Annu. Rev. Public Health 2000 21 : 15 46.
4. van Rie A, Warren R, Richardson M, Victor TC, Gie RP et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 1999 341 : 1174 9.
5. Pawelec G, Effros RB, Caruso C, Remarque E, Barnett Y et al. T cells and aging (update February 1999). Front. Biosci. 1999 4 : D216 69.
6. Jepson A, Fowler A, Banya W, Singh M, Bennett S et al. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect. Immun. 2001 69 : 3989 94.
7. Jung SB, Yang CS, Lee JS, Shin AR, Jung SS et al. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect. Immun. 2006 74 : 2686 96.
8. Jung SB, Song CH, Yang CS, Kim SY, Lee KS et al. Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-alpha and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis. J. Clin. Immunol. 2005 25 : 482 90.
9. Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 2001 166 : 7033 41.
10. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995 2 : 561 72.
11. Berner MD, Sura ME, Alves BN, Hunter KW. IFN-gamma primes macrophages for enhanced TNF-alpha expression in response to stimulatory and non-stimulatory amounts of microparticulate beta-glucan. Immunol. Lett. 2005 98 : 115 22.
12. Ehlers S, Benini J, Kutsch S, Endres R, Rietschel ET et al. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumour necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 1999 67 : 3571 9.
13. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect. Immun. 2001 69 : 1847 55.
14. Othieno C, Hirsch CS, Hamilton BD. Interaction of Mycobacterium tuberculosis-induced transforming growth factor β1 and interleukin-10. Infect. Immun. 1999 67 : 5730 5.
15. Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 1996 64 : 913 8.
16. Song CH, Kim HJ, Park JK, Lim JH, Kim UO et al. Depressed IL-12, but not IL-18 production in response to a 30- and 32-kDa mycobacterial antigen in patients with active pulmonary tuberculosis. Infect. Immun. 2000 68 : 4477 84.
17. Torres M, Herrera T, Villareal H, Rich EA, Sada E et al. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 1998 66 : 176 80.
18. Lee JS, Song CH, Kim CH, Kong SJ, Shon MH et al. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin. Exp. Immunol. 2002 128 : 516 24.
19. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2003 167 : 970 5.
20. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J. Infect. Dis. 2002 186 : 1463 8.
21. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 1998 113 : 401 6.
22. Scola L, Crivello A, Marino V, Gioia V, Serauto A et al. IL-10 and TNF-α polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech. Ageing Dev. 2003 124 : 569 72.
23. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl. Immunol. 1999 7 : 127 8.
24. Lee JS, Song CH, Kim CH, Kong SJ, Shon MH et al. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Med. Microbiol. Immunol. (Berl) 2003 192 : 61 9.
25. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol. 1999 66 : 562 6.
26. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR et al. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinb.) 2001 81 : 335 41.
27. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998 279 : 226 8.
28. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997 24 : 1 8.
29. Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) 2000 39 : 1180 90.
30. Henao MI, Montes C, Paris SC, Garcia LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis (Edinb.) 2006 86 : 11 9.
31. Abbas Z, Moatter T. Interleukin (IL) 1beta and IL-10 gene polymorphism in chronic hepatitis C patients with normal or elevated alanine aminotransferase levels. J. Pak. Med. Assoc. 2003 53 : 59 62.